CD274 and undifferentiated pleomorphic sarcoma: However, recently the SARC028 trial report described that only 4% (3/70) of the sarcoma biopsy samples (all three were from patients with UPS) were immunopositive for PD-L1 in more than 1% of tumor cells [14].